Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Serebrovskaya EO et al. - Antibody-photosensitizer chemical conjugates are used successfully to kill cancer cells in photodynamic therapy. 4D5scFv-KillerRed showed fine targeting properties and efficiently killed p185HER-2-ECD-expressing cancer cells upon light irradiation. It also showed a remarkable additive effect with the commonly used antitumor agent cisplatin, further demonstrating the potential of the approach.

Today in Adverse Effects/Events...keeping you current

Surgery in the Patient with Endocrine Dysfunction
Anesthesiology Clinics, 12/02/09

Obesity, Metabolic Syndrome, and the Surgical Patient
Anesthesiology Clinics, 12/02/09

Innate immunity, coagulation and placenta-related adverse pregnancy outcomes
Thrombosis Research, 11/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address